Bilateral horizontal gaze palsy as the only manifestation of demyelination in the central nervous system
https://doi.org/10.30629/2658-7947-2022-27-4-81-85
Abstract
Isolated oculomotor disorders caused by central nervous system damage are quite rare. As a rule, they are combined with other signs of cerebral trunk damage. A clinical case with the focus of amyelination in the cerebral trunk area, which manifests itself in the form of bilateral horizontal gaze palsy in the absence of other focal neurological symptoms is presented. A complete regression of oculomotor disorders was observed against the background of glucocorticosteroid therapy. A differential research was carried out among amyelinating, ophthalmic, endocrinologic diseases, ANCA-associated vasculitis (AAV).
About the Authors
S. A. Mamykina
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
A.Ya. Kozhevnikov Clinic of Nervous System Diseases, Department of Nervous System Diseases and Neurosurgery
Moscow
O. N. Voskresenskaya
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
A.Ya. Kozhevnikov Clinic of Nervous System Diseases, Department of Nervous System Diseases and Neurosurgery
Moscow
T. E. Shmidt
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
A.Ya. Kozhevnikov Clinic of Nervous System Diseases, Department of Nervous System Diseases and Neurosurgery
Moscow
V. V. Grinyuk
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
A.Ya. Kozhevnikov Clinic of Nervous System Diseases, Department of Nervous System Diseases and Neurosurgery
Moscow
References
1. Liabeikо T.Y, Hardzeyeu Y.Y., Shamava T.M., Bojka D.V. Pseudotomurous demyelination with remitting multiple sclerosis. Medical news. 2019;2(293):16–20. (In Russian).
2. Andermatten J.A., Elua Pinin A., Samprón Lebed N., Bollar Zabala A., Arrazola Schlamilch M., Urculo Bareño E. Fisher one-and-a-half syndrome due to a bulb protuberance cavernoma. Arch Soc Esp Oftalmol (Engl Ed). 2019;94(6):309–312. English, Spanish. https://doi.org/10.1016/j.oftal.2018.10.005 Epub 2018 Nov 16. PMID: 30455115
3. Xue F., Zhang L., Zhang L., Ying Z., Sha O., Ding Y. One-and-a-half syndrome with its spectrum disorders. Quant Imaging Med Surg. 2017;7(6):691–697. doi: 10.21037/qims.2017.12.04 PMID: 29312874; PMCID: PMC5756788
4. Shmidt T.E., Pronin I.N., Kazansev K.Yu., Voskresenskaya O.N., Damulin I.V., Aleksandrov A.A., Yakhno N.N. CLIPPERS syndrome. Neurology, neuropsychiatry, psychosomatics. 2018;10(2):76–82. (In Russ.). https://doi.org/10.14412/2074-2711-2018-2-76-82
5. Grimm S.A., Chamberlain M.C. Brainstem glioma: a review. Current neurology and neuroscience reports. 2013;13(5):346. https://doi.org/10.1007/s11910-013-0346-3
6. Parfenov V.A., Isaikin A.I., Shchapova A.A., Balashova S.V. Bilateral horizontal paralysis of gaze in exacerbation of multiple sclerosis. Neurological journal. 2010;15(3):15–18. (In Russ.).
7. Subekti I., Soewondo P., Soebardi S., Darmowidjojo B., Harbuwono D.S., Purnamasari D. et al. Practical Guidelines Management of Graves Ophthalmopathy. Acta Med Indones. 2019;51(4):364–371. PMID: 32041923
8. Bartalena L., Kahaly G.J., Baldeschi L., Dayan C.M., Eckstein A., Marcocci C. et al. EUGOGO. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. European journal of endocrinology. 2021;185(4):G43–G67. https://doi.org/10.1530/EJE-21-0479
9. Kondratev S.A., Kondrateva E.A., Ternovykh I.K., Alekseeva I.K., Nazarov R.V., Kondratev A.N. Ulitin A.Yu. Miller–Fisher syndrome. Russian journal of anaesthesiology and reanimatology. 2019;1:68–73. (In Russi.). https://doi.org/10.17116/anaesthesiology201901168
10. Panshin G.A. On the issue of modern radiotherapy of brain stem gliomas in adult patients. Difficult patient. 2021;19(2):54–56. (In Russ.). https://doi.org/10.24412/2074-1995-2021-2-54-56
11. André R., Cottin V., Saraux J.L., Blaison G., Bienvenu B., Cathebras P. et al. French Vasculitis Study Group (FVSG). Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg–Strauss): Report of 26 patients and review of the literature. Autoimmunity reviews. 2017;16(9):963–969. https://doi.org/10.1016/j.autrev.2017.07.007
12. Vodopivec I., Rizzo J.F., 3rd. Ophthalmic manifestations of giant cell arteritis. Rheumatology (Oxford, England). 2018;57(2):63–72. https://doi.org/10.1093/rheumatology/kex428
13. Ruina E.A., Borovkov S.N., Parshina E.V., Grigorieva V.N., Smirnov A.A. Sjogren’s disease with cerebral symptoms. Clinical observation. Difficult patient. 2020;4(18):10–16. (In Russ.). https://doi.org/10.24411/2074-1995-2020-10023
14. Khafizova I.F., Popova N.A., Yakupov E.Z. A case of acute disseminated encefalomyelitis with let onset (clinical observation). 2014;7(2):193–198. (In Russian).
15. Shmidt T.E. According to the materials of the congress ECTRIMS (European Committee for Treatment and Research of Multiple Sclerosis), 2017, Paris. Neurological journal. 2018;23(4):201–210. (In Russ.). https://doi.org/10.18821/1560-9545-2018-23-4-201-210
16. Heckmann J., Todorova M., Müller S., Broser P.J., Sturm V. First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis. Erste klinische Erfahrungen mit Anti-Myelin-Oligodendrozyten-Glykoprotein-Antikörper-positiver Optikusneuritis. Klinische Monatsblatter fur Augenheilkunde. 2020;237(4):458–463. https://doi.org/10.1055/a-1068-2506
17. Thompson A.J., Banwell B.L., Barkhof F., Carroll W.M., Coetzee T., Comi G. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology. 2018;17(2):162–173. https://doi.org/10.1016/S1474-4422(17)30470-2
18. Förster M., Graf J., Mares J., Aktas O., Hartung H.P., Kremer D. Drug Treatment of Clinically Isolated Syndrome. CNS drugs. 2019;33(7):659–676. https://doi.org/10.1007/s40263-019-00647-x
19. Ewe R., White O.B., Burke A. Isolated Horizontal Gaze Palsy: Observations and Explanations. Frontiers in neurology. 2017;8:611. https://doi.org/10.3389/fneur.2017.00611
Review
For citations:
Mamykina S.A., Voskresenskaya O.N., Shmidt T.E., Grinyuk V.V. Bilateral horizontal gaze palsy as the only manifestation of demyelination in the central nervous system. Russian neurological journal. 2022;27(4):81-85. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-4-81-85
Views:
557
Email this article 